NASDAQ:CLOV Clover Health Investments Q2 2026 Earnings Results & Report $4.79 +0.21 (+4.59%) Closing price 10/9/2026 04:00 PM EasternExtended Trading$4.81 +0.02 (+0.40%) As of 10/9/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Clover Health Investments beat analyst expectations on both earnings and revenue in its Q2 2026 results, released August 5, 2026. The company reported EPS of $0.05 versus the $0.0386 consensus estimate, while revenue of $743.17 million topped the $728.27 million estimate by $14.90 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ2 2026Report DateAugust 5, 2026TimeAfter Market ClosesConference Call5:00 PM ET Clover Health Investments EPS ResultsActual EPS$0.05Consensus EPS $0.0386Beat/MissBeat by +$0.0114One Year Ago EPSN/AEPS Beat Rate5 of last 8 quartersClover Health Investments Revenue ResultsActual Revenue$743.17 millionExpected Revenue$728.27 millionBeat/MissBeat by +$14.90 millionYoY Revenue GrowthN/AUpcoming EarningsClover Health Investments' Q3 2026 earnings is estimated for Wednesday, November 4, 2026, based on past reporting schedules, with a conference call scheduled at 5:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q3 2026 Earnings ReportConference Call ResourcesConference Call AudioConference Call TranscriptSlide DeckPress Release (8-K)Quarterly Report (10-Q)SEC FilingEarnings HistoryCompany ProfileConference Call Audio Live Call not available Earnings Conference CallClover Health Investments Q2 202600:00 / 00:00Speed:1x1.25x1.5x2xSlide DeckFull Screen Slide DeckPowered by Earnings DocumentsSlide DeckPress Release(8-K)Quarterly report(10-Q) Clover Health Investments Q2 2026 Earnings FAQ Did Clover Health Investments beat earnings estimates for Q2 2026? Clover Health Investments (NASDAQ:CLOV) reported earnings of $0.05 per share for Q2 2026, beating the consensus estimate of $0.0386. The report was announced on Wednesday, August 5, 2026. What was Clover Health Investments' revenue for Q2 2026? Clover Health Investments reported revenue of $743.17 million for Q2 2026, against a consensus estimate of $728.27 million. Where can I read Clover Health Investments' Q2 2026 earnings call transcript? The full Clover Health Investments Q2 2026 earnings conference call transcript is published on this page, including prepared remarks and the analyst Q&A session, along with the participants who spoke on the call. When is Clover Health Investments' next earnings date? Clover Health Investments' next earnings date is estimated for Wednesday, November 4, 2026. MarketBeat tracks confirmed and estimated earnings dates for Clover Health Investments on the company's earnings history page. Clover Health Investments Earnings HeadlinesClover Health Investments (CLOV) Is Up 9.4% After Securing 5-Star PPO CMS Rating For 2027October 11 at 1:03 AM | finance.yahoo.comIs Clover Health Stock Too Dependent On One Group Of Members?October 9 at 1:56 PM | finance.yahoo.comIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.October 11 at 1:00 AM | Banyan Hill Publishing (Ad)Clover Health Investments Climbs After PPO Medicare Advantage Plans Rated Five StarsOctober 9 at 1:18 AM | marketwatch.comClover Health Medicare Advantage PPO Plans Earn 5 Star Rating for 2027October 8 at 6:45 PM | globenewswire.comAt 67, He’ll Keep His Clover Medicare Advantage Plan for 2027. The Premium Will Stay $0. The Most He Can Be Billed Will Jump $1,144October 8 at 7:00 AM | 247wallst.comSee More Clover Health Investments Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Clover Health Investments? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Clover Health Investments and other key companies, straight to your email. Email Address About Clover Health InvestmentsClover Health Investments (NASDAQ:CLOV) is a healthcare technology and Medicare Advantage company headquartered in Franklin, Tennessee. Through its insurance subsidiary, Clover Health Insurance Company, the company offers Medicare Advantage plans to eligible beneficiaries in select counties across the United States. Its plans are designed to provide coverage for hospital, medical and supplemental healthcare services through a managed-care structure. Clover’s technology platform, Clover Assistant, is intended to support physicians by organizing patient information, identifying potential care needs and helping providers coordinate treatment. The platform is designed to give clinicians data-driven insights during patient visits while helping Clover manage care for its Medicare Advantage members. Clover Health was founded in 2012 and became a publicly traded company in 2021 through a business combination with Social Capital Hedosophia Holdings Corp. III. The company has focused primarily on the Medicare Advantage market and has also participated in value-based care initiatives. Andrew Toy serves as chief executive officer, having previously held technology leadership roles at Clover.View Clover Health Investments ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 10/05 - 10/09Delta Air Lines Faces a Fuel Crisis—But There's a Silver LiningPalantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis ReformPepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
